Literature DB >> 31848645

Prevalence of Osteosarcopenia and Its Association with Cardiovascular Risk Factors in Iranian Older People: Bushehr Elderly Health (BEH) Program.

Noushin Fahimfar1, Farbod Zahedi Tajrishi2, Safoora Gharibzadeh3, Gita Shafiee4, Kiarash Tanha5, Ramin Heshmat4, Iraj Nabipour6, Alireza Raeisi7, Ali Jalili1, Bagher Larijani8, Afshin Ostovar9.   

Abstract

Osteosarcopenia is an increasingly recognized geriatric syndrome with a considerable prevalence which increases morbidity and mortality. Although osteosarcopenia is a result of age-related deterioration in muscle and bone, there are many risk factors that provoking osteosarcopenia. These risk factors should be considered by the clinicians to treat osteosarcopenia. We assessed the link between osteosarcopenia and conventional risk factors of cardiovascular diseases. This study was a cross-sectional study that has been conducted within the framework of Bushehr Elderly Health (BEH) program stage II in which participants aged ≥ 60 years were included. Osteopenia/osteoporosis was defined as a t-score ≤  - 1.0 standard deviation below the mean values of a young healthy adult. We defined sarcopenia as reduced skeletal muscle mass plus low muscle strength and/or low physical performance. Osteosarcopenia was considered as the presence of both osteopenia/osteoporosis and sarcopenia. We estimated the age-standardized prevalence of osteosarcopenia for men and women, separately. Using modified Poisson regression analysis, adjusted prevalence ratio (PR) with 95% CI was used to show the measure of associations in the final model. Among 2353 participants, 1205 (51.2%) were women. Age-standardized prevalence of osteosarcopenia was 33.8 (95% CI 31.0-36.5) in men and 33.9 (30.9-36.8) in women. In both sexes, the inverse association was detected with body mass index and having osteosarcopenia (PR 0.84, 95% CI 0.81-0.88 in men and 0.77, 95% CI 0.74-0.80 in women). In both sexes, high-fat mass was positively associated with osteosarcopenia [PR 1.46 (95% CI 1.11-1.92) in men, and 2.25 (95% CI 1.71-2.95) in women]. Physical activity had a significant inverse association in men (PR = 0.64, 95% CI 0.46, 0.88), but not in women. Diabetes was also showed a direct association with osteosarcopenia in men (PR 1.33, 95% CI 1.04-1.69). No associations were detected between the lipid profiles and osteosarcopenia. Results demonstrated a high prevalence of osteosarcopenia in both sexes suggesting a high disease burden in a rapidly aging country. Lifestyle and socioeconomic factors, as well as chronic diseases, were significantly associated with osteosarcopenia.

Entities:  

Keywords:  Elderly; Iran; Osteoporosis; Osteosarcopenia; Prevalence; Sarcopenia

Mesh:

Year:  2019        PMID: 31848645     DOI: 10.1007/s00223-019-00646-6

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  12 in total

1.  Effect of a six-week times restricted eating intervention on the body composition in early elderly men with overweight.

Authors:  Przemysław Domaszewski; Mariusz Konieczny; Paweł Pakosz; Katarzyna Łukaniszyn-Domaszewska; Wioletta Mikuláková; Ewa Sadowska-Krępa; Steve Anton
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

2.  Osteosarcopenia and type 2 diabetes mellitus in post-menopausal women: a case-control study.

Authors:  Antimo Moretti; Angela Palomba; Francesca Gimigliano; Marco Paoletta; Sara Liguori; Francesco Zanfardino; Giuseppe Toro; Giovanni Iolascon
Journal:  Orthop Rev (Pavia)       Date:  2022-10-13

3.  Sarcopenia screening strategies in older people: a cost effectiveness analysis in Iran.

Authors:  Ali Darvishi; Mohsen Rezaei Hemami; Gita Shafiee; Rajabali Daroudi; Mahsa Mohseni; Farkhondeh Hosseini Shekarabi; Ramin Heshmat
Journal:  BMC Public Health       Date:  2021-05-17       Impact factor: 3.295

4.  Bone Mass Loss and Sarcopenia in Ecuadorian Patients.

Authors:  M Intriago; G Maldonado; R Guerrero; O D Messina; C Rios
Journal:  J Aging Res       Date:  2020-03-17

Review 5.  Related Factors and Clinical Outcomes of Osteosarcopenia: A Narrative Review.

Authors:  Tatsuro Inoue; Keisuke Maeda; Ayano Nagano; Akio Shimizu; Junko Ueshima; Kenta Murotani; Keisuke Sato; Kazuki Hotta; Shinichiro Morishita; Atsuhiro Tsubaki
Journal:  Nutrients       Date:  2021-01-20       Impact factor: 5.717

6.  The association of cardio-metabolic risk factors and history of falling in men with osteosarcopenia: a cross-sectional analysis of Bushehr Elderly Health (BEH) program.

Authors:  Noushin Fahimfar; Shakiba Yousefi; Sima Noorali; Safoora Gharibzadeh; Mahnaz Sanjari; Kazem Khalagi; Ahmad Mehri; Gita Shafiee; Ramin Heshmat; Iraj Nabipour; Azam Amini; Amirhossein Darabi; Gholamreza Heidari; Bagher Larijani; Afshin Ostovar
Journal:  BMC Geriatr       Date:  2022-01-11       Impact factor: 3.921

7.  Association between biomarkers of bone health and osteosarcopenia among Iranian older people: The Bushehr Elderly Health (BEH) program.

Authors:  Maryam Fathi; Ramin Heshmat; Mehdi Ebrahimi; Ahmad Salimzadeh; Afshin Ostovar; Ali Fathi; Farideh Razi; Iraj Nabipour; Maryam Moghaddassi; Gita Shafiee
Journal:  BMC Geriatr       Date:  2021-11-19       Impact factor: 3.921

8.  Association between osteosarcopenia and coronary artery calcification in asymptomatic individuals.

Authors:  Chul-Hyun Park; Yong-Taek Lee; Kyung Jae Yoon
Journal:  Sci Rep       Date:  2022-04-04       Impact factor: 4.379

9.  Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers.

Authors:  Ben Kirk; Jesse Zanker; Gustavo Duque
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-03-22       Impact factor: 12.910

Review 10.  A Call to Action: Now Is the Time to Screen Elderly and Treat Osteosarcopenia, a Position Paper of the Italian College of Academic Nutritionists MED/49 (ICAN-49).

Authors:  Tiziana Montalcini; Arturo Pujia; Lorenzo M Donini; Lucia Frittitta; Fabio Galvano; Andrea Natali; Loris Pironi; Marisa Porrini; Patrizia Riso; Angela Albarosa Rivellese; Diego Russo; Giovanni Scapagnini; Mauro Serafini; Anna Tagliabue; Antonino De Lorenzo
Journal:  Nutrients       Date:  2020-08-31       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.